首页> 美国卫生研究院文献>Case Reports in Dermatology >Adult Onset of BRAFV600E-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining
【2h】

Adult Onset of BRAFV600E-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining

机译:免疫组织化学染色成功诊断BRAFV600E突变的朗格汉斯细胞组织细胞增生症伴皮肤累及的成人发作。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Langerhans cell histiocytosis (LCH) is characterized by the clonal proliferation of Langerhans cells; it is categorized as a single-system disease with single or multifocal lesions, and as a multi-system disease with or without the risk of organ involvement. Although the skin is not categorized as a risk organ, the precise diagnosis of skin lesions is necessary to determine the protocol for the treatment of LCH. In this report, we describe a 28-year-old Japanese man with adult onset of BRAFV600E-mutated LCH with cutaneous involvement successfully diagnosed by immunohistochemical staining. Our report suggests that immunohistochemical staining for the BRAFV600E gene could be a diagnostic tool to determine the clinical type of LCH.
机译:朗格汉斯细胞组织细胞增生症(LCH)的特征在于朗格汉斯细胞的克隆增殖。它被分类为具有单灶或多灶病变的单系统疾病,以及有或没有器官受累风险的多系统疾病。尽管未将皮肤归类为危险器官,但对皮肤病变的精确诊断对于确定LCH的治疗方案是必要的。在本报告中,我们描述了一名28岁的日本男子,其成年人BRAF V600E 突变型LCH起病,并通过免疫组织化学染色成功诊断出皮肤受累。我们的报告表明,BRAF V600E 基因的免疫组织化学染色可能是确定LCH临床类型的诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号